Nugenerex Immuno-oncology, Inc. Shares Outstanding
Nugenerex Immuno-oncology, Inc. had Shares Outstanding of 100.30 million shares as of 2021-04-30, per its 10-Q filed 2021-06-14.
Prices
us-gaap:CommonStockSharesOutstanding · last filed 2021-06-14
- 2021-04-30: Common Stock, Shares, Outstanding 100.30M shares.
- 2021-01-31: Common Stock, Shares, Outstanding 400.30M shares.
- 2020-10-31: Common Stock, Shares, Outstanding 400.30M shares.
- 2020-07-31: Common Stock, Shares, Outstanding 400.30M shares.
| Period end | Common Stock, Shares, Outstanding |
|---|---|
| 2021-04-30 | 100.30M shares 10-Q · filed 2021-06-14 |
| 2021-01-31 | 400.30M shares 10-Q · filed 2021-03-12 |
| 2020-10-31 | 400.30M shares 10-Q · filed 2020-12-15 |
| 2020-07-31 | 400.30M shares 10-Q · filed 2021-06-14 |
| 2020-04-30 | 400.00M shares 10-Q · filed 2020-06-19 |
| 2020-01-31 | 400.00M shares 10-Q · filed 2020-06-17 |
| 2019-07-31 | 400.00M shares 10-K · filed 2020-10-29 |